UPDATE 1-Genzyme, CHC lift Sanofi's first-quarter figures, upbeat on Dupixent

PARIS, April 28 (Reuters) - French drugmaker Sanofi reported higher-than-expected first-quarter profits on Friday, buoyed by its speciality care division Genzyme, vaccines and consumer products acquired from Germany's Boehringer Ingelheim.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.